Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY-NC-NDBMC health services research

Healthcare workers' perceptions of the potential value of whole-genome sequencing for post-exposure management of rifampicin-resistant tuberculosis: a qualitative study.

6 affiliations
  1. 1Division of Immunology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. [email protected].
  2. 2Division of Immunology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  3. 3Family Medicine and Population Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  4. 4DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  5. 5Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Cape Town, South Africa.
  6. 6Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Abstract

Background

Rifampicin-resistant tuberculosis (RR-TB) remains a public health challenge, with suboptimal treatment outcomes and challenging management of contacts. Whole genome sequencing (WGS) generates a comprehensive drug resistance profile and transmission inference with a single assay. Limited evidence exists on how healthcare workers (HCWs) perceive the value of WGS, especially for post-exposure management.Methods

We conducted a qualitative study with 22 purposively sampled HCWs (9 doctors, 9 nurses, 4 community health workers) at 11 public health care facilities in the Western Cape, South Africa. Following a standardized explanation of WGS and WGS-guided post-exposure management, semi-structured interviews were conducted to elicit responses on anticipated acceptability and value of WGS for post-exposure management. Interviews were audio-recorded, transcribed, and analysed using thematic analysis, combining inductive with deductive approaches informed by the Theoretical Framework of Acceptability themes of intervention coherence, self-efficacy, affective attitude, ethicality, perceived effectiveness and opportunity costs.Results

HCWs demonstrated good anticipated intervention coherence, even though nurses and community health workers required more explanation on WGS than doctors, and pathways for WGS integration into routine care were not clear. Most HCWs indicated high confidence in anticipated application of WGS-supported recommendations. Limited familiarity with genomic tools was identified as a barrier that requires formal training. Affective attitudes were largely positive, with HCWs expressing optimism about improved clinical decision-making and reduced diagnostic uncertainty following access to WGS. Anticipated effectiveness was high, with HCWs hopeful of faster initiation of appropriate regimens for patients and contacts, reduced patient distress, and decreased medication wastage. Less applicable to post-exposure management was the anticipated benefit that WGS could reduce the burden to the health system and patients by limiting repeat visits and reducing laboratory delays. Ethicality emerged as an important advantage, with HCWs anticipating reduced stigma when contact screening is guided by the detection of hotspots. HCWs did not anticipate opportunity costs.Conclusion

HCWs in high-burden settings generally anticipated that WGS would be acceptable to inform post-exposure management strategies. Successful integration of WGS into routine TB care will require tailored training and clear implementation guidance on how to interpret and apply WGS results in clinical and public health practice.Clinical trial number

Not applicable.

Related

  1. “The way I am being treated matters more to me than the TB itself”: experiences of stigma in healthcare settings among people with drug-resistant tuberculosis in Lagos, Nigeria: a qualitative study
    Olusola A. Adejumo, Firoza Haffejee, Olusoji Daniel +1
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  2. Healthcare workers’ perceptions of ethnic-racial relations in the workplace: a qualitative study
    Patricia Lima Ferreira Santa Rosa, Rondinelli Salvador Silva, Maria Laura Gaeta Hipólito da Silva +4
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthFrontiers
  3. Microarray patches as a potential alternative to injectable fertility medications: a qualitative study of patients’ and healthcare professionals’ perceptions
    Laura Koenitz, Megan Quigley, Abina Crean +2
    International Journal of Clinical PharmacyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  4. Healthcare providers perceptions of barriers and facilitators to implementation of an acute traumatic brain injury clinical practice guideline: a CFIR-informed qualitative study at a regional referral hospital in Northern Tanzania
    V. F. Saria, G. G. Zaccheus, J. R. N. Vissoci +9
    medRxivPreprintCC0Full textEpidemiology & public healthmedRxiv
  5. Chinese women's perceptions and needs regarding the AI-assisted tools for self-management of chronic perineal pain: a qualitative study.
    Weiwei Ding, Jiawen Wang, Yaping Hu +3
    BMC women's healthPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
BibTeX
@article{october2026healthcare,
  title = {{Healthcare workers' perceptions of the potential value of whole-genome sequencing for post-exposure management of rifampicin-resistant tuberculosis: a qualitative study.}},
  author = {Caitlin D October and Busisiwe Beko and Anja Reuter and Vincent Rennie and Nabila Ismail and Emilyn Costa Conceição and Susanne Tonsing and Rob Warren and Stephanus Malherbe and Annelies Van Rie and Lario Viljoen},
  journal = {BMC health services research},
  year = {2026},
  month = jul,
  doi = {10.1186/s12913-026-15140-7},
  url = {https://europepmc.org/article/MED/42907804},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Healthcare workers' perceptions of the potential value of whole-genome sequencing for post-exposure management of rifampicin-resistant tuberculosis: a qualitative study.
AU  - Caitlin D October
AU  - Busisiwe Beko
AU  - Anja Reuter
AU  - Vincent Rennie
AU  - Nabila Ismail
AU  - Emilyn Costa Conceição
AU  - Susanne Tonsing
AU  - Rob Warren
AU  - Stephanus Malherbe
AU  - Annelies Van Rie
AU  - Lario Viljoen
PY  - 2026
DA  - 2026/07/01
JO  - BMC health services research
DO  - 10.1186/s12913-026-15140-7
UR  - https://europepmc.org/article/MED/42907804
AB  - Background  Rifampicin-resistant tuberculosis (RR-TB) remains a public health challenge, with suboptimal treatment outcomes and challenging management of contacts. Whole genome sequencing (WGS) generates a comprehensive drug resistance profile and transmission inference with a single assay. Limited evidence exists on how healthcare workers (HCWs) perceive the value of WGS, especially for post-exposure management.Methods  We conducted a qualitative study with 22 purposively sampled HCWs (9 doctors, 9 nurses, 4 community health workers) at 11 public health care facilities in the Western Cape, South Africa. Following a standardized explanation of WGS and WGS-guided post-exposure management, semi-structured interviews were conducted to elicit responses on anticipated acceptability and value of WGS for post-exposure management. Interviews were audio-recorded, transcribed, and analysed using thematic analysis, combining inductive with deductive approaches informed by the Theoretical Framework of Acceptability themes of intervention coherence, self-efficacy, affective attitude, ethicality, perceived effectiveness and opportunity costs.Results  HCWs demonstrated good anticipated intervention coherence, even though nurses and community health workers required more explanation on WGS than doctors, and pathways for WGS integration into routine care were not clear. Most HCWs indicated high confidence in anticipated application of WGS-supported recommendations. Limited familiarity with genomic tools was identified as a barrier that requires formal training. Affective attitudes were largely positive, with HCWs expressing optimism about improved clinical decision-making and reduced diagnostic uncertainty following access to WGS. Anticipated effectiveness was high, with HCWs hopeful of faster initiation of appropriate regimens for patients and contacts, reduced patient distress, and decreased medication wastage. Less applicable to post-exposure management was the anticipated benefit that WGS could reduce the burden to the health system and patients by limiting repeat visits and reducing laboratory delays. Ethicality emerged as an important advantage, with HCWs anticipating reduced stigma when contact screening is guided by the detection of hotspots. HCWs did not anticipate opportunity costs.Conclusion  HCWs in high-burden settings generally anticipated that WGS would be acceptable to inform post-exposure management strategies. Successful integration of WGS into routine TB care will require tailored training and clear implementation guidance on how to interpret and apply WGS results in clinical and public health practice.Clinical trial number  Not applicable.
SN  - 1472-6963
ER  -